Alterations in the nuclear architecture produced by the overexpression of tau protein in neuroblastoma cells

Journal of Alzheimer's Disease

Volumn 36, Issue 3, 2013, Pages 503-520

  Monroy Ramírez, Hugo C ^a   Basurto Islas, Gustavo ^b   Mena, Raul ^a   Cisneros, Bulmaro ^a   Binder, Lester I ^c   Avila, Jesús ^d   Garcia Sierra, Francisco ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b DEPARTAMENTO DE PROCESOS Y TECNOLOGÍA   (Mexico)

^c NORTHWESTERN UNIVERSITY   (United States)

^d CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

Author keywords

Alzheimer's disease; confocal microscopy; Lamins; microtubules; nuclear architecture; tau pathology; truncated tau

Indexed keywords

LAMIN; TAU PROTEIN; TUBULIN;

ARTICLE; CELL AGING; CELL COMPARTMENTALIZATION; CELL CULTURE; CELL CYCLE; CELL DEATH; CELL NUCLEUS MEMBRANE; CELL STRUCTURE; CONTROLLED STUDY; CYTOPLASM; CYTOSKELETON; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NEUROBLASTOMA CELL; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

EID: 84881401406     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-122401     Document Type: Article

References (79)

1. Spillantini MG, Goedert M (1998) Tau protein pathology in neurodegenerative diseases. Trends Neurosci 21, 428-433
2. Iqbal K, Wang X, Blanchard J, Liu F, Gong CX, Grundke-Iqbal I (2010) Alzheimer's disease neurofibrillary degeneration: Pivotal and multifactorial. Biochem Soc Trans 38, 962-966
3. Hoozemans JJ, van Haastert ES, Nijholt DA, Rozemuller AJ, Eikelenboom P, Scheper W (2009) The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus. Am J Pathol 174, 1241-1251
4. García-Sierra F, Basurto-Islas G, Jarero-Basulto J, Monroy-Ramírez HC, Torres-Cruz FM, Cort'es Callejas H, Camarillo-Rojas HM, Kristofikova Z, Ripova D, Luna-Münoz J, Mena R, Binder LI and Mondragón-Rodriíguez S (2011) Pathological stages of abnormally processed tau protein during its aggregation into fibrillary structures. In Alzheimer's Disease Pathogenesis-Core Concepts, Shifting Paradigms and Therapeutic Targets, de la Monte S, Ed. InTech, Croatia, pp. 131-156
5. Sato S, Tatebayashi Y, Akagi T, Chui DH, Murayama M, Miyasaka T, Planel E, Tanemura K, Sun X, Hashikawa T, Yoshioka K, Ishiguro K, Takashima A (2002) Aberrant tau phosphorylation by glycogen synthase kinase-3beta and JNK3 induces oligomeric tau fibrils in COS-7 cells. J Biol Chem 277, 42060-42065
6. Mookherjee P, Johnson GV (2001) Tau phosphorylation during apoptosis of human SH-SY5Y neuroblastoma cells. Brain Res 921, 31-43
7. Shelton SB, Johnson GV (2001) Tau and HMW tau phosphorylation and compartmentalization in apoptotic neuronal PC12 cells. J Neurosci Res 66, 203-213
8. Fath T, Eidenmuller J, BrandtR(2002) Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease. J Neurosci 22, 9733-9741
9. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaff E, Wauters E, van Baren J, Hillebrand M, Joosse M, Kwon JM, Nowotny P, Che LK, Norton J, Morris JC, Reed LA, Trojanowski J, Basun H, Lannfelt L, Neystat M, Fahn S, Dark F, Tannenberg T, Dodd PR, Hayward N, Kwok JB, Schofield PR, Andreadis A, Snowden J, Craufurd D, Neary D, Owen F, Oostra BA, Hardy J, Goate A, van Swieten J, Mann D, Lynch T, Heutink P (1998) Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705
10. Waxman EA, Giasson BI (2011) Induction of intracellular tau aggregation is promoted by alpha-synuclein seeds and provides novel insights into the hyperphosphorylation of tau. J Neurosci 31, 7604-7618
11. Krishnamurthy PK, Johnson GV (2004) Mutant (R406W) human tau is hyperphosphorylated and does not efficiently bind microtubules in a neuronal cortical cell model. J Biol Chem 279, 7893-7900
12. Zhao Z, Ho L, Suh J, QinW, Pyo H, Pompl P, Ksiezak-Reding H, Pasinetti GM (2003) A role of P301L tau mutant in antiapoptotic gene expression, cell cycle and apoptosis. Mol Cell Neurosci 24, 367-379
13. Novak M (1994) Truncated tau protein as a new marker for Alzheimer's disease. Acta Virol 38, 173-189
14. Mena R, Edwards PC, Harrington CR, Mukaetova-Ladinska EB, Wischik CM (1996) Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer's disease. Acta Neuropathol 91, 633-641
15. Garcia-Sierra F, Ghoshal N, Quinn B, Berry RW, Binder LI (2003) Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease. J Alzheimers Dis 5, 65-77
16. Garcia-Sierra F, Mondragon-Rodriguez S, Basurto-Islas G (2008) Truncation of tau protein and its pathological significance in Alzheimer's disease. J Alzheimers Dis 14, 401-409
17. Basurto-Islas G, Luna-Munoz J, Guillozet-Bongaarts AL, Binder LI, Mena R, Garcia-Sierra F (2008) Accumulation of aspartic acid421-And glutamic acid391-cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease. J Neuropathol Exp Neurol 67, 470-483
18. Garcia-Sierra F, Jarero-Basulto JJ, Kristofikova Z, Majer E, Binder LI, Ripova D (2012) Ubiquitin is associated with early truncation of tau protein at aspartic acid(421) during the maturation of neurofibrillary tangles in Alzheimer's disease. Brain Pathol 22, 240-250
19. Mondragon-Rodriguez S, Mena R, Binder LI, Smith MA, Perry G, Garcia-Sierra F (2008) Conformational changes and cleavage of tau in Pick bodies parallel the early processing of tau found in Alzheimer pathology. Neuropathol Appl Neurobiol 34, 62-75
20. Mondraǵon-Rodŕiguez S, Binder LI, Garćia-Sierra F (2009) Conformational changes and cleavage; are these responsible for the tau aggregation in Alzheimer's disease? Future Neurol 4, 39-53
21. Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL, Lu M, FuY, Garcia-Sierra F, LaPointe N, Miller R, Berry RW, Binder LI, Cryns VL (2003) Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci U S A 100, 10032-10037
22. Fasulo L, Ugolini G, Cattaneo A (2005) Apoptotic effect of caspase-3 cleaved tau in hippocampal neurons and its potentiation by tau FTDP-mutation N279K. J Alzheimers Dis 7, 3-13
23. Fasulo L, Ugolini G, Visintin M, Bradbury A, Brancolini C, Verzillo V, Novak M, Cattaneo A (2000) The neuronal microtubule-Associated protein tau is a substrate for caspase-3 and an effector of apoptosis. J Neurochem 75, 624-633
24. Cho JH, Johnson GV (2004) Glycogen synthase kinase 3 beta induces caspase-cleaved tau aggregation in situ. J Biol Chem 279, 54716-54723
25. Quintanilla RA, Matthews-Roberson TA, Dolan PJ, Johnson GV (2009) Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: Implications for the pathogenesis of Alzheimer disease. J Biol Chem 284, 18754-18766
26. Matthews-Roberson TA, Quintanilla RA, Ding H, Johnson GV(2008) Immortalized cortical neurons expressing caspasecleaved tau are sensitized to endoplasmic reticulum stress induced cell death. Brain Res 1234, 206-212
27. Mann DM, Neary D, Yates PO, Lincoln J, Snowden JS, Stanworth P (1981) Alterations in protein synthetic capability of nerve cells in Alzheimer's disease. J Neurol Neurosurg Psychiatry 44, 97-102
28. Metuzals J, Robitaille Y, Houghton S, Gauthier S, Leblanc R (1988) Paired helical filaments and the cytoplasmic-nuclear interface in Alzheimer's disease. J Neurocytol 17, 827-833
29. Sheffield LG, Miskiewicz HB, Tannenbaum LB, Mirra SS (2006) Nuclear pore complex proteins in Alzheimer disease. J Neuropathol Exp Neurol 65, 45-54
30. Su JH, Cummings BJ, Cotman CW (1994) Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites. Neuroreport 5, 2358-2362
31. Loomis PA, Howard TH, Castleberry RP, Binder LI (1990) Identification of nuclear tau isoforms in human neuroblastoma cells. Proc Natl Acad Sci U S A 87, 8422-8426
32. Papasozomenos SC (1995) Nuclear tau immunoreactivity in presenile dementia with motor neuron disease: A case report. Clin Neuropathol 14, 100-104
33. Ke Y, Dramiga J, Schutz U, Kril JJ, Ittner LM, Schroder H, Gotz J (2012) Tau-mediated nuclear depletion and cytoplasmic accumulation of SFPQ in Alzheimer's and Pick's disease. PLoS One 7, e35678
34. Uberti D, Rizzini C, Spano PF, Memo M (1997) Characterization of tau proteins in human neuroblastoma SH-SY5Y cell line. Neurosci Lett 235, 149-153
35. DeBusk FL (1972) The Hutchinson-Gilford progeria syndrome. Report of 4 cases and reviewof the literature. J Pediatr 80, 697-724
36. Goldman RD, Shumaker DK, Erdos MR, Eriksson M, Goldman AE, Gordon LB, Gruenbaum Y, Khuon S, Mendez M, Varga R, Collins FS (2004) Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A 101, 8963-8968
37. Dahl KN, Ribeiro AJ, Lammerding J (2008) Nuclear shape, mechanics, and mechanotransduction. Circ Res 102, 1307-1318
38. Dahl KN, Booth-Gauthier EA, Ladoux B(2010) In the middle of it all: Mutual mechanical regulation between the nucleus and the cytoskeleton. J Biomech 43, 2-8
39. Denizot F, Lang R (1986) Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89, 271-277
40. Fulga TA, Elson-Schwab I, Khurana V, Steinhilb ML, Spires TL, Hyman BT, Feany MB (2007) Abnormal bundling and accumulation of F-Actin mediates tau-induced neuronal degeneration in vivo. Nat Cell Biol 9, 139-148
41. Santa-Maria I, Hernandez F, Del Rio J, Moreno FJ, Avila J (2007) Tramiprosate, a drug of potential interest for the treatment of Alzheimer's disease, promotes an abnormal aggregation of tau. Mol Neurodegener 6, 2-17
42. Goldman RD, GruenbaumY, Moir RD, Shumaker DK, Spann TP (2002) Nuclear lamins: Building blocks of nuclear architecture. Genes Dev 16, 533-547
43. Dijkhuis AJ, Klappe K, Jacobs S, Kroesen BJ, Kamps W, Sietsma H,Kok JW(2006)PDMPsensitizes neuroblastoma to paclitaxel by inducing aberrant cell cycle progression leading to hyperploidy. Mol Cancer Ther 5, 593-601
44. Binder LI, Frankfurter A, Rebhun LI (1985) The distribution of tau in the mammalian central nervous system. J Cell Biol 101, 1371-1378
45. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-Associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83, 4913-4917
46. Braak E, Braak H, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87, 554-567
47. Avila J (2006) Tau phosphorylation and aggregation in Alzheimer's disease pathology. FEBS Lett 580, 2922-2927
48. Iqbal K, Liu F, Gong CX, Alonso Adel C, Grundke-Iqbal I (2009) Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 18, 53-69
49. Ebneth A, Godemann R, Stamer K, Illenberger S, Trinczek B, Mandelkow E (1998) Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: Implications for Alzheimer's disease. J Cell Biol 143, 777-794
50. Morfini G, Pigino G, Beffert U, Busciglio J, Brady ST (2002) Fast axonal transport misregulation and Alzheimer's disease. Neuromolecular Med 2, 89-99
51. Roy S, Zhang B, Lee VM, Trojanowski JQ (2005) Axonal transport defects: A common theme in neurodegenerative diseases. Acta Neuropathol 109, 5-13
52. LaPointe NE, Morfini G, Pigino G, Gaisina IN, Kozikowski AP, Binder LI, Brady ST (2009) The amino terminus of tau inhibits kinesin-dependent axonal transport: Implications for filament toxicity. J Neurosci Res 87, 440-451
53. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239-259
54. Arriagada PV, Marzloff K, Hyman BT (1992) Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 42, 1681-1688
55. Yu JZ, Kuret J, Rasenick MM (2002) Transient expression of fluorescent tau proteins promotes process formation in PC12 cells: Contributions of the tau C-terminus to this process. J Neurosci Res 67, 625-633
56. Samsonov A, Yu JZ, Rasenick M, Popov SV (2004) Tau interaction with microtubules in vivo. J Cell Sci 117, 6129-6141
57. Esmaeli-Azad B, McCarty JH, Feinstein SC (1994) Sense and antisense transfection analysis of tau function: Tau influences net microtubule assembly, neurite outgrowth and neuritic stability. J Cell Sci 107, 869-879
58. Wang HH, Li HL, Liu R, Zhang Y, Liao K,Wang Q,Wang JZ, Liu SJ (2010) Tau overexpression inhibits cell apoptosis with the mechanisms involving multiple viability-related factors. J Alzheimers Dis 21, 167-179
59. Liu XA, Song J, Jiang Q, Wang Q, Tian Q, Wang JZ (2012) Expression of the hyperphosphorylated tau attenuates ER stress-induced apoptosis with upregulation of unfolded protein response. Apoptosis 17, 1039-1049
60. Tsukane M, Yamauchi T (2006) Increase in apoptosis with neural differentiation and shortening of the lifespan of P19 cells overexpressing tau. Neurochem Int 48, 243-254
61. Tsukane M, Yoshizaki C, Yamauchi T (2007) Development and specific induction of apoptosis of cultured cell models overexpressing human tau during neural differentiation: Implication in Alzheimer's disease. Anal Biochem 360, 114-122
62. Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 156, 1051-1063
63. Cereghetti GM, Stangherlin A, Martins de Brito O, Chang CR, Blackstone C, Bernardi P, Scorrano L (2008) Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc Natl Acad Sci U S A 105, 15803-15808
64. Mirra SS,Wood JG, Pollock NJ, Bakay RA, Binder LI, Ellisman MH (1987) New observations on the fine structure of Alzheimer's disease. Exp Neurol 46, 377-390
65. Smale G, Nichols NR, Brady DR, Finch CE, Horton WE (1995) Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 133, 225-230
66. Friedlander RM (2003) Apoptosis and caspases in neurodegenerative diseases. N Engl J Med 348, 1365-1375
67. Oberhammer FA, Hochegger K, Froschl G, Tiefenbacher R, Pavelka M (1994) Chromatin condensation during apoptosis is accompanied by degradation of lamin A+B, without enhanced activation of cdc2 kinase. J Cell Biol 126, 827-837
68. Chang KH, Multani PS, Sun KH,Vincent F, de PabloY, Ghosh S, Gupta R, Lee HP, Lee HG, Smith MA, Shah K (2011) Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death. Mol Biol Cell 22, 1452-1462
69. Vaughan OA, A-RM, Bridger JM, Broers JLV, Ramaekers FCS, Wehnert M, Morris GE, Whitfield WGF, Hutchison CJ (2001) Both emerin, and lamin C depend on lamin. A for localization at the nuclear envelope. J Cell Sci 114, 2577-2590
70. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W (1996) Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382, 638-642
71. Molenaar M, van de Wetering M, Oosterwegel M, Peterson-Maduro J, Godsave S, Korinek V, Roose J, Destree O, Clevers H (1996) XTcf-3 transcription factor mediates beta-catenininduced axis formation in Xenopus embryos. Cell 86, 391-399
72. Markiewicz E, Tilgner K, Barker N, van de Wetering M, Clevers H, DorobekM,Hausmanowa-Petrusewicz I, Ramaekers FC, Broers JL, Blankesteijn WM, Salpingidou G, Wilson RG, Ellis JA, Hutchison CJ (2006) The inner nuclear membrane protein emerin regulates beta-catenin activity by restricting its accumulation in the nucleus. The EMBO J 25, 3275-3285
73. Li HL,Wang HH, Liu SJ, Deng YQ, Zhang YJ, Tian Q,Wang XC, Chen XQ, Yang Y, Zhang JY, Wang Q, Xu H, Liao FF, Wang JZ (2007) Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration. Proc Natl Acad Sci U S A 104, 3591-3596
74. Baker PB, Baba N, Boesel CP (1981) Cardiovascular abnormalities in progeria. Case report and review of the literature. Arch Pathol Lab Med 105, 384-386
75. Taimen P, Pfleghaar K, Shimi T, Moller D, Ben-Harush K, Erdos MR, Adam SA, Herrmann H, Medalia O, Collins FS, Goldman AE, Goldman RD (2009) A progeria mutation reveals functions for lamin A in nuclear assembly, architecture, and chromosome organization. Proc Natl Acad Sci U S A 106, 20788-20793
76. Beaudouin J, Gerlich D, Daigle N, Eils R, Ellenberg J (2002) Nuclear envelope breakdown proceeds by microtubuleinduced tearing of the lamina. Cell 108, 83-96
77. Salpingidou G, Smertenko A, Hausmanowa-Petrucewicz I, Hussey PJ, Hutchison CJ (2007) A novel role for the nuclear membrane protein emerin in association of the centrosome to the outer nuclear membrane. J Cell Biol 178, 897-904
78. Patel VP, Chu CT (2011) Nuclear transport, oxidative stress, and neurodegeneration. Int J Clin Exp Pathol 4, 215-229
79. Carmel G, Mager EM, Binder LI, Kuret J (1996) The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J Biol Chem 271, 32789-32795